Plain-English translation of NCT06678594 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The CYCLOPES trial is testing a systematic, step-by-step approach to treating severely calcified (hardened) blockages in the heart's arteries. Doctors will use high-definition ultrasound imaging to guide them in choosing and performing the best calcium-softening technique for each patient's specific blockage, then place an Everolimus eluting stent—a special mesh tube coated with medication that helps prevent the artery from closing again. The goal is to improve how well the procedure works and how patients fare over time.
Calcium deposits that harden inside coronary arteries make them very difficult to treat with standard stenting procedures. This trial exists to test whether a structured, ultrasound-guided plan for softening the calcium before stent placement can lead to better outcomes and fewer complications for patients with severely calcified heart disease.
You likely qualify if…
You likely don't qualify if…
You will undergo a cardiac catheterization procedure where doctors use ultrasound imaging to map your calcified blockage before and after treating it with a calcium-softening technique. Once the calcium is softened, they will place a special coated stent into the artery using standard stenting techniques, and image it once more afterward to ensure good placement. You will need to take dual blood-thinning medications (aspirin and a P2Y12 inhibitor) for at least 3 months following the procedure and attend follow-up visits as directed by the study team.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
Ireland